New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes

Human epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications

(2013) F. Montemurro et al.   ANNALS OF ONCOLOGY

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Clinical Characteristics and Survival Analysis of Breast Cancer Molecular Subtypes with Hepatic Metastases

(2013) Qi-Dong Ge et al.   Asian Pacific Journal of Cancer Prevention

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era

(2013) Erin M. Olson et al.   BREAST

A new genome-driven integrated classification of breast cancer and its implications

(2013) Sarah-Jane Dawson et al.   EMBO JOURNAL

Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010

(2012) A. García Fernández et al.   BREAST

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

(2012) Nancy U. Lin et al.   CANCER

The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer

(2011) Xiao Feng Duan et al.   International Journal of Clinical Oncology

Effect of Very Small Tumor Size on Cancer-Specific Mortality in Node-Positive Breast Cancer

(2011) Jennifer Y. Wo et al.   JOURNAL OF CLINICAL ONCOLOGY

Metastatic Behavior of Breast Cancer Subtypes

(2010) Hagen Kennecke et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

(2009) E M Azzato et al.   BRITISH JOURNAL OF CANCER

Cancer micrometastases

(2009) Klaus Pantel et al.   Nature Reviews Clinical Oncology

The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine

(2009) J. S. Ross et al.   ONCOLOGIST

Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer

(2008) Ibtisam Lale Atahan et al.   ACTA ONCOLOGICA

Factors affecting the prognosis of breast cancer patients with brain metastases

(2008) Pinar Saip et al.   BREAST

Subtypes of Breast Cancer Show Preferential Site of Relapse

(2008) M. Smid et al.   CANCER RESEARCH

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Multiplexed Cell Signaling Analysis of Human Breast Cancer Applications for Personalized Therapy

(2008) Julia D. Wulfkuhle et al.   JOURNAL OF PROTEOME RESEARCH